# Radiofrequency Ablation in Resectable Colorectal Lung Metastasis

> **NCT00776399** · PHASE2 · COMPLETED · sponsor: **Mie University** · enrollment: 70 (actual)

## Conditions studied

- Lung Metastasis
- Colorectal Cancer

## Interventions

- **DEVICE:** Lung radiofrequency ablation

## Key facts

- **NCT ID:** NCT00776399
- **Lead sponsor:** Mie University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2017-12-01
- **Final completion:** 2018-08-31
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2019-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00776399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00776399, "Radiofrequency Ablation in Resectable Colorectal Lung Metastasis". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00776399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*